Hispidulin is a multitarget natural anticancer substance, and the main targets involved in different cancers are also different, but the AKT pathway and the ERK pathway may be the main regulatory points for hispidulin to inhibit cancer cell growth [11,13]. Here, AKT1 is linked to cancer.